Since its debut in 2015, Profhilo® has revolutionised the European regenerative medicine market. This pioneering injectable has redefined natural aesthetics nearly a decade after its launch. With more than eight million treatments administered globally, misconceptions persist with some inaccurately describing Profhilo® as just an ‘injectable moisturiser’ or ‘skin booster’.
To commemorate the 10th anniversary of Profhilo®, it’s time to clarify the true impact and benefits of this transformative treatment, with the up-to-date insight from the latest study, ‘Intradermal Injection of Hybrid Complexes of High- and Low-Molecular-Weight Hyaluronan: Where Do We Stand and Where Are We Headed in Regenerative Medicine?’ by Humzah et al., (published in the International Journal of Molecular Sciences in 2024).
The study highlights how Profhilo® differs significantly from other treatments, such as linear hyaluronic acid used in mesotherapy which often includes vitamins, amino acids and peptides, and from…
